Beijing’s move to simplify the process for approving oral proprietary Chinese medicine (PCM) from Hong Kong to be sold across the border has created new opportunities for firms in the city to exploit the mainland’s 450 billion yuan (US$62.8 billion) market, according to Hong Kong’s trade promotion body. The streamlined procedures have opened a more…
The European Union has unveiled sweeping plans to slash its reliance on China and reclaim control over critical sectors – from chemicals to pharmaceuticals and biotech – as it steps up its de-risking plans. On Wednesday the bloc unveiled three separate proposals – an action plan for the chemicals industry, a medical countermeasures strategy and…
US President Donald Trump during a cabinet meeting at the White House in Washington, DC, US, on Tuesday, July 8, 2025. Aaron Schwartz | Bloomberg | Getty Images President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.” “They’re going to be tariffs at very…
AstraZeneca CEO Pascal Soriot, pictured in London on June 28, 2023, reportedly wants to move the company’s stock listing from London to the United States. Justin Tallis | Afp | Getty Images Pressure is piling on London’s stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet…
Tuesday marks the first day of trading for the second half of 2025. It was a rocky six months for the U.S. stock market and the Club’s 30-name portfolio as investors weighed President Donald Trump’s tariffs, ongoing geopolitical conflict and the Federal Reserve’s next monetary policy decision. The market ebbed and flowed, but ultimately ended…
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Monday said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company’s sales…